An Open-label, Randomized Two-way, Cross-over Study to Compare Meal-and-carbohydrate-announcement Strategy Versus Meal-annoucement Strategy During Closed-loop Regulation of Glucose Levels in a Morning Meal in Adults With Type-1 Diabetes.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Glucagon (Primary) ; Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 10 Dec 2012 Biomarkers information updated
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2012 New trial record